What this means
Despite decades of intensive investigation, rheumatoid arthritis (RA) remains a therapeutic challenge, primarily attributed to its intricate pathological microenvironment and poorly elucidated etiology. However, mitochondrial dysfunction and abnormal activation of the cGAS-STING signaling pathway play a key role in RA.
A plain-English summary is on its way. Until then, this is the start of the authors' own summary.
- Who it was tested in
- People
- Kind of research
- A study
The science
- Original title
- Engineered Mitochondria-Targeted Biomimetic Hybrid Nanovesicles Ameliorate Rheumatoid Arthritis via Regulating Macrophage Autophagy and cGAS-STING Signaling.
- Authors
- Lu L, Su Y, Zheng L et al.
- Journal
- ACS applied materials & interfaces
- Published
- Sep 8, 2026
- Study type
- Study · in humans
- PMID
- 42709510 ↗
Abstract
Despite decades of intensive investigation, rheumatoid arthritis (RA) remains a therapeutic challenge, primarily attributed to its intricate pathological microenvironment and poorly elucidated etiology. However, mitochondrial dysfunction and abnormal activation of the cGAS-STING signaling pathway play a key role in RA. Herein, we report mitochondria targeted biomimetic nanovesicles (SS31-CB@MM-FNVs/CLT) for the targeted therapy of RA. SS31-CB@MM-FNVs/CLT is constructed by macrophage membrane fusion nanovesicles, which are encapsulated with celastrol (CLT) and functionalized with the chitosan-bilirubin (CS-BR) conjugate and SS-31 peptide. SS31-CB@MM-FNVs/CLT bypasses immune surveillance and prolongs circulatory persistence through macrophage membrane fusion, targets macrophage mitochondria by CS and SS-31 peptide decoration, and scavenges reactive oxygen species (ROS), activates autophagy, and repolarizes macrophages from the M1 to M2 subtypes through the synergistic effects of bilirubin, celastrol, and the nanoplatform. In general, SS31-CB@MM-FNVs/CLT exhibits therapeutic efficacy in vitro and in vivo by scavenging ROS, inhibiting the STING pathway, and enhancing autophagy, thereby regulating macrophage polarization. Taken together, this biomimetic nanoplatform provides a promising basis for safer and more potent therapeutic interventions.
Lu L, Su Y, Zheng L et al. Engineered Mitochondria-Targeted Biomimetic Hybrid Nanovesicles Ameliorate Rheumatoid Arthritis via Regulating Macrophage Autophagy and cGAS-STING Signaling. ACS applied materials & interfaces. 2026. doi:10.1021/acsami.6c13918. PMID: 42709510. https://pubmed.ncbi.nlm.nih.gov/42709510/
Related research
The Role of Oxidative Stress in Heart Failure: Mechanisms and Therapeutic Targets.
Heart failure is characterised by increased production of reactive oxygen species (ROS), which contribute to apoptotic signalling.
A peptide eased signs of aging in heart cells damaged by a cancer drug
Researchers treated heart muscle cells in a dish with a cancer drug, then a peptide called SS-31. The peptide reduced several signs of aging, but not cell cycle arrest. This was done only in lab cells, so it does not show the peptide would help people.
Two drugs together eased stroke brain damage in mice
Researchers gave mice two compounds, alone and together, after a stroke-like injury to the brain. The mice given both had less brain damage and better nerve function than those given either one alone.
Peptide SS-31 eased radiation-caused aging signs in heart cells
Researchers exposed heart cells to radiation and gave some of them SS-31. SS-31 reduced several aging signs, but this was only tested in cells, not people.
Targeting Mitochondria for Postoperative Cognitive Dysfunction: From Mechanisms to Therapeutics.
Postoperative cognitive dysfunction (POCD) is a frequent neurological complication in older surgical patients, leading to substantial declines in quality of life and placing a considerable burden on society.
Two mitochondria-targeted drugs studied in aged female mice with fatty liver disease
Researchers gave two drugs to older mice with fatty liver disease caused by a rich diet. Both drugs improved liver markers in the mice, but this does not show they would help people.
See all research on Elamipretide (SS-31) →